Lu S - Search Results

1

Evaluation of the VeriStrat^® serum protein test in patients with advanced squamous cell carcinoma of the lung treated with second-line afatinib or erlotinib in the phase III LUX-Lung 8 study.

Gadgeel S, Goss G, Soria JC, Felip E, Georgoulias V, Lu S, Cobo M, Syrigos K, Lee KH, Göker E, Guclu SZ, Isla D, Morabito A, Dupuis N, Bühnemann C, Krämer N, Solca F, Ehrnrooth E, Ardizzoni A. Gadgeel S, et al. Among authors: lu s. Lung Cancer. 2017 Jul;109:101-108. doi: 10.1016/j.lungcan.2017.05.010. Epub 2017 May 11. Lung Cancer. 2017. PMID: 28577938 Free article. Clinical Trial.

2

Predictive significance of bone sialoprotein and osteopontin for bone metastases in resected Chinese non-small-cell lung cancer patients: a large cohort retrospective study.

Zhang L, Hou X, Lu S, Rao H, Hou J, Luo R, Huang H, Zhao H, Jian H, Chen Z, Liao M, Wang X. Zhang L, et al. Among authors: lu s. Lung Cancer. 2010 Jan;67(1):114-9. doi: 10.1016/j.lungcan.2009.03.017. Lung Cancer. 2010. PMID: 19376608

3

Pemetrexed monotherapy versus pemetrexed plus platinum combination as second-line treatment for advanced non-small cell lung cancer.

Zhang YF, Chen ZW, Lu S. Zhang YF, et al. Among authors: lu s. Chin Med J (Engl). 2009 Oct 20;122(20):2472-6. Chin Med J (Engl). 2009. PMID: 20079162

4

[Safety analysis of ambulatory chemotherapy in lung cancer].

Feng Y, Lu S, Song Z, Xu L, Shi Y, Chen Z. Feng Y, et al. Among authors: lu s. Zhongguo Fei Ai Za Zhi. 2010 Jul;13(7):713-6. doi: 10.3779/j.issn.1009-3419.2010.07.10. Zhongguo Fei Ai Za Zhi. 2010. PMID: 20673488 Free PMC article. Chinese.

5

Erlotinib as a salvage treatment for patients with advanced non-small cell lung cancer after failure of gefitinib treatment.

Song ZB, Yu YF, Chen ZW, Lu S. Song ZB, et al. Among authors: lu s. Chin Med J (Engl). 2011 Aug;124(15):2279-83. Chin Med J (Engl). 2011. PMID: 21933557

6

[Efficacy of gemcitabine and vinorelbine in first-line treatment with advanced non-small cell lung cancer: a multicentre retrospective study].

Yu Y, Zhang L, Ren Z, Zhao J, Li Z, Lu S. Yu Y, et al. Among authors: lu s. Zhongguo Fei Ai Za Zhi. 2012 May;15(5):281-6. doi: 10.3779/j.issn.1009-3419.2012.05.06. Zhongguo Fei Ai Za Zhi. 2012. PMID: 22613334 Free PMC article. Chinese.

7

The synergistic effect of EGFR tyrosine kinase inhibitor gefitinib in combination with aromatase inhibitor anastrozole in non-small cell lung cancer cell lines.

Shen L, Li Z, Shen S, Niu X, Yu Y, Li Z, Liao M, Chen Z, Lu S. Shen L, et al. Among authors: lu s. Lung Cancer. 2012 Dec;78(3):193-200. doi: 10.1016/j.lungcan.2012.08.012. Epub 2012 Sep 15. Lung Cancer. 2012. PMID: 22985911

8

[Gemcitabine combined with vinorelbine in the treatment of refractory patients with advanced non-small cell lung cancer: a multi-center retrospective study].

Lu S, Zhang L, Yu Y, Chen G, Zhao Q. Lu S, et al. Zhongguo Fei Ai Za Zhi. 2012 Sep;15(9):507-12. doi: 10.3779/j.issn.1009-3419.2012.09.02. Zhongguo Fei Ai Za Zhi. 2012. PMID: 22989453 Free PMC article. Clinical Trial. Chinese.

9

Regulation of SIRT2 levels for human non-small cell lung cancer therapy.

Li Z, Xie QR, Chen Z, Lu S, Xia W. Li Z, et al. Among authors: lu s. Lung Cancer. 2013 Oct;82(1):9-15. doi: 10.1016/j.lungcan.2013.05.013. Epub 2013 Jul 31. Lung Cancer. 2013. PMID: 23915912

10

[Research status on targeted therapy for squamous cell lung cancer].

Yuan H, Lu S. Yuan H, et al. Among authors: lu s. Zhongguo Fei Ai Za Zhi. 2013 Oct 20;16(10):559-63. doi: 10.3779/j.issn.1009-3419.2013.10.11. Zhongguo Fei Ai Za Zhi. 2013. PMID: 24113011 Free PMC article. Review. Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

17,113 results

Search Page

Filters